Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benzyl alcohol - Shionogi Pharma

Drug Profile

Benzyl alcohol - Shionogi Pharma

Alternative Names: Head Lice Asphyxiator; LARx - Shionogi Pharma; Pediculosis therapy - Shionogi Pharma; Ulesfia

Latest Information Update: 11 Feb 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Summers Laboratories
  • Developer Concordia Pharmaceuticals; Shionogi Pharma
  • Class Alcohols; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pediculosis

Most Recent Events

  • 11 Feb 2016 No recent reports on development identified - Preregistration for Pediculosis in Canada (Topical)
  • 30 Dec 2013 Preregistration for Pediculosis in Canada (Topical)
  • 07 May 2013 Benzyl alcohol lotion exclusively licensed to Concordia Pharmaceuticals worldwide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top